229 related articles for article (PubMed ID: 23095610)
21. Impact of blood transfusions on recurrence and survival after rectal cancer surgery.
Jagoditsch M; Pozgainer P; Klingler A; Tschmelitsch J
Dis Colon Rectum; 2006 Aug; 49(8):1116-30. PubMed ID: 16779711
[TBL] [Abstract][Full Text] [Related]
22. Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery.
Dupuis JY; Bart B; Bryson G; Robblee J
CMAJ; 1999 Apr; 160(7):997-1002. PubMed ID: 10207338
[TBL] [Abstract][Full Text] [Related]
23. The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer.
De Oliveira GS; Schink JC; Buoy C; Ahmad S; Fitzgerald PC; McCarthy RJ
Transfus Med; 2012 Apr; 22(2):97-103. PubMed ID: 22151920
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes of an integrated transfusion reduction initiative in patients undergoing resection for colorectal cancer.
Van Osdol AD; Borgert AJ; Kallies KJ; Froman JP; Bottner WA; Shapiro SB
Am J Surg; 2015 Dec; 210(6):990-4; discussion 995. PubMed ID: 26455522
[TBL] [Abstract][Full Text] [Related]
25. Association between venous thromboembolism and perioperative allogeneic transfusion.
Nilsson KR; Berenholtz SM; Garrett-Mayer E; Dorman T; Klag MJ; Pronovost PJ
Arch Surg; 2007 Feb; 142(2):126-32; discussion 133. PubMed ID: 17309963
[TBL] [Abstract][Full Text] [Related]
26. Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases.
Correa-Gallego C; Gonen M; Fischer M; Grant F; Kemeny NE; Arslan-Carlon V; Kingham TP; Dematteo RP; Fong Y; Allen PJ; D'Angelica MI; Jarnagin WR
Ann Surg Oncol; 2013 Aug; 20(8):2477-84. PubMed ID: 23608971
[TBL] [Abstract][Full Text] [Related]
27. Adverse effects of perioperative blood transfusion in patients with colorectal cancer.
Jahnson S; Andersson M
Eur J Surg; 1992 Aug; 158(8):419-25. PubMed ID: 1356481
[TBL] [Abstract][Full Text] [Related]
28. Association of perioperative allogeneic blood transfusions and prognosis of patients with gastric cancer after curative gastrectomy.
Zhou HY; Yi W; Wang J; Zhang J; Wang WJ; Hu ZQ
Am J Surg; 2014 Jul; 208(1):80-7. PubMed ID: 24262934
[TBL] [Abstract][Full Text] [Related]
29. The effect of blood transfusions on survival after surgery for colorectal cancer.
Busch OR; Hop WC; Marquet RL; Jeekel J
Eur J Cancer; 1995; 31A(7-8):1226-8. PubMed ID: 7577027
[TBL] [Abstract][Full Text] [Related]
30. Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors.
Bufalari A; Giustozzi G; Burattini MF; Servili S; Bussotti C; Lucaroni E; Ricci E; Sciannameo F
J Surg Oncol; 2006 Mar; 93(3):173-80. PubMed ID: 16482596
[TBL] [Abstract][Full Text] [Related]
31. Young age is not a poor prognostic marker in colorectal cancer.
Chung YF; Eu KW; Machin D; Ho JM; Nyam DC; Leong AF; Ho YH; Seow-Choen F
Br J Surg; 1998 Sep; 85(9):1255-9. PubMed ID: 9752871
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?
Peeples C; Shellnut J; Wasvary H; Riggs T; Sacksner J
Dis Colon Rectum; 2010 Nov; 53(11):1517-23. PubMed ID: 20940600
[TBL] [Abstract][Full Text] [Related]
33. The impact of perioperative allogeneic blood transfusion on survival in elderly patients with colorectal cancer.
Kaneko M; Sasaki S; Ishimaru K; Terai E; Nakayama H; Watanabe T
Anticancer Res; 2015 Jun; 35(6):3553-8. PubMed ID: 26026124
[TBL] [Abstract][Full Text] [Related]
34. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.
Magaji BA; Moy FM; Roslani AC; Law CW
BMC Cancer; 2017 May; 17(1):339. PubMed ID: 28521746
[TBL] [Abstract][Full Text] [Related]
35. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
Anannamcharoen S; Boonya-Ussadol C
J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
[TBL] [Abstract][Full Text] [Related]
36. [Clinical effects of blood transfusion-associated immune modulation on outcome of tumor surgery].
Heiss MM; Mempel W; Delanoff C; Mempel M; Jauch KW; Schildberg FW
Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():25-9. PubMed ID: 8374284
[TBL] [Abstract][Full Text] [Related]
37. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer.
Vignali A; Braga M; Dionigi P; Radaelli G; Gentilini O; Bellini A; Jemos V; Di Carlo V
Eur J Surg; 1995 Jul; 161(7):487-92. PubMed ID: 7488662
[TBL] [Abstract][Full Text] [Related]
38. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
39. The impact of an integrated transfusion reduction initiative in patients undergoing resection for colorectal cancer.
Froman JP; Mathiason MA; Kallies KJ; Bottner WA; Shapiro SB
Am J Surg; 2012 Dec; 204(6):944-50; discussion 950-1. PubMed ID: 23022253
[TBL] [Abstract][Full Text] [Related]
40. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
